Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study
Introduction Intravenous lipid emulsions (ILE) have been credited for successful resuscitation in drug intoxication cases where other cardiac life-support methods have failed. However, inter-individual variability can function as a confounder that challenges our ability to define the scope of effica...
Gespeichert in:
Veröffentlicht in: | Drugs in R&D 2021-09, Vol.21 (3), p.305-320 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 320 |
---|---|
container_issue | 3 |
container_start_page | 305 |
container_title | Drugs in R&D |
container_volume | 21 |
creator | McDaniel, Matthew Flores, Kevin B. Akpa, Belinda S. |
description | Introduction
Intravenous lipid emulsions (ILE) have been credited for successful resuscitation in drug intoxication cases where other cardiac life-support methods have failed. However, inter-individual variability can function as a confounder that challenges our ability to define the scope of efficacy for lipid interventions, particularly as relevant data are scarce. To address this challenge, we developed a quantitative systems pharmacology model to predict outcome variability and shed light on causal mechanisms in a virtual population of rats subjected to bupivacaine toxicity and ILE intervention.
Materials and Methods
We combined a physiologically based pharmacokinetic–pharmacodynamic model with data from a small study in Sprague-Dawley rats to characterize individual-specific cardiac responses to lipid infusion. We used the resulting individual parameter estimates to posit a population distribution of responses to lipid infusion. On that basis, we constructed a large virtual population of rats (
N
= 10,000) undergoing lipid therapy following bupivacaine cardiotoxicity.
Results
Using unsupervised clustering to assign resuscitation endpoints, our simulations predicted that treatment with a 30% lipid emulsion increases bupivacaine median lethal dose (LD
50
) by 46% when compared with a simulated control fluid. Prior experimental findings indicated an LD
50
increase of 48%. Causal analysis of the population data suggested that muscle accumulation rather than liver accumulation of bupivacaine drives survival outcomes.
Conclusion
Our results represent a successful prediction of complex, dynamic physiological outcomes over a virtual population. Despite being informed by very limited data, our mechanistic model predicted a plausible range of treatment outcomes that accurately predicts changes in LD
50
when extrapolated to putatively toxic doses of bupivacaine. Furthermore, causal analysis of the predicted survival outcomes indicated a critical synergy between scavenging and direct cardiotonic mechanisms of ILE action. |
doi_str_mv | 10.1007/s40268-021-00353-4 |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral_osti_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8363697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8363697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-532972c5031a033e828c8a3136d7067f59968eb837bd7578555ab75fc8789e503</originalsourceid><addsrcrecordid>eNp9kctu1TAURSMEog_4AUYWc4Mdx48wQCq30Fa6iKpAp5ZjO-2pUjuynavej-CfSZqqEhNGtuSz1pH3rqp3lHyghMiPuSG1UJjUFBPCOMPNi-qQUtli0RL68vHeYK6UOKiOcr4jhFAm1OvqgDW1bFXTHFZ_LpN3YAuEG3QRik8YgoMduMkM6NokMB0MUPbodErLzBZGcOjK5ylbKKZADCj26Ms0ws5YA8GjjUkOYokPYBcQAroyJX9CJ-gaUlm8l3GchpX9Hp0fFvHPMrn9m-pVb4bs3z6dx9Xvb19_bc7x9sfZxeZki23DScGc1a2sLSeMGsKYV7WyyrD5c04SIXvetkL5TjHZOcml4pybTvLeKqlaP2PH1efVO07dvXfWh5LMoMcE9ybtdTSg_30JcKtv4k4rJpho5Sx4vwpiLqCXKLy9tTEEb4umiihRL1vqdcimmHPy_fMCSvTSoF4b1HOD-rFB3cwQW6E8LoH7pO_ilMKcxv-ovy9Rn6s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Springer Nature OA Free Journals</source><creator>McDaniel, Matthew ; Flores, Kevin B. ; Akpa, Belinda S.</creator><creatorcontrib>McDaniel, Matthew ; Flores, Kevin B. ; Akpa, Belinda S. ; Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)</creatorcontrib><description>Introduction
Intravenous lipid emulsions (ILE) have been credited for successful resuscitation in drug intoxication cases where other cardiac life-support methods have failed. However, inter-individual variability can function as a confounder that challenges our ability to define the scope of efficacy for lipid interventions, particularly as relevant data are scarce. To address this challenge, we developed a quantitative systems pharmacology model to predict outcome variability and shed light on causal mechanisms in a virtual population of rats subjected to bupivacaine toxicity and ILE intervention.
Materials and Methods
We combined a physiologically based pharmacokinetic–pharmacodynamic model with data from a small study in Sprague-Dawley rats to characterize individual-specific cardiac responses to lipid infusion. We used the resulting individual parameter estimates to posit a population distribution of responses to lipid infusion. On that basis, we constructed a large virtual population of rats (
N
= 10,000) undergoing lipid therapy following bupivacaine cardiotoxicity.
Results
Using unsupervised clustering to assign resuscitation endpoints, our simulations predicted that treatment with a 30% lipid emulsion increases bupivacaine median lethal dose (LD
50
) by 46% when compared with a simulated control fluid. Prior experimental findings indicated an LD
50
increase of 48%. Causal analysis of the population data suggested that muscle accumulation rather than liver accumulation of bupivacaine drives survival outcomes.
Conclusion
Our results represent a successful prediction of complex, dynamic physiological outcomes over a virtual population. Despite being informed by very limited data, our mechanistic model predicted a plausible range of treatment outcomes that accurately predicts changes in LD
50
when extrapolated to putatively toxic doses of bupivacaine. Furthermore, causal analysis of the predicted survival outcomes indicated a critical synergy between scavenging and direct cardiotonic mechanisms of ILE action.</description><identifier>ISSN: 1174-5886</identifier><identifier>EISSN: 1179-6901</identifier><identifier>DOI: 10.1007/s40268-021-00353-4</identifier><identifier>PMID: 34279844</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>60 APPLIED LIFE SCIENCES ; Internal Medicine ; Medicine ; Medicine & Public Health ; Original ; Original Research Article ; Pharmacology/Toxicology ; Pharmacotherapy</subject><ispartof>Drugs in R&D, 2021-09, Vol.21 (3), p.305-320</ispartof><rights>UT-Battelle, LLC 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-532972c5031a033e828c8a3136d7067f59968eb837bd7578555ab75fc8789e503</citedby><cites>FETCH-LOGICAL-c450t-532972c5031a033e828c8a3136d7067f59968eb837bd7578555ab75fc8789e503</cites><orcidid>0000-0002-6098-7113 ; 0000-0002-4000-6971 ; 0000000240006971 ; 0000000260987113</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363697/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363697/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.osti.gov/biblio/1808620$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>McDaniel, Matthew</creatorcontrib><creatorcontrib>Flores, Kevin B.</creatorcontrib><creatorcontrib>Akpa, Belinda S.</creatorcontrib><creatorcontrib>Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)</creatorcontrib><title>Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study</title><title>Drugs in R&D</title><addtitle>Drugs R D</addtitle><description>Introduction
Intravenous lipid emulsions (ILE) have been credited for successful resuscitation in drug intoxication cases where other cardiac life-support methods have failed. However, inter-individual variability can function as a confounder that challenges our ability to define the scope of efficacy for lipid interventions, particularly as relevant data are scarce. To address this challenge, we developed a quantitative systems pharmacology model to predict outcome variability and shed light on causal mechanisms in a virtual population of rats subjected to bupivacaine toxicity and ILE intervention.
Materials and Methods
We combined a physiologically based pharmacokinetic–pharmacodynamic model with data from a small study in Sprague-Dawley rats to characterize individual-specific cardiac responses to lipid infusion. We used the resulting individual parameter estimates to posit a population distribution of responses to lipid infusion. On that basis, we constructed a large virtual population of rats (
N
= 10,000) undergoing lipid therapy following bupivacaine cardiotoxicity.
Results
Using unsupervised clustering to assign resuscitation endpoints, our simulations predicted that treatment with a 30% lipid emulsion increases bupivacaine median lethal dose (LD
50
) by 46% when compared with a simulated control fluid. Prior experimental findings indicated an LD
50
increase of 48%. Causal analysis of the population data suggested that muscle accumulation rather than liver accumulation of bupivacaine drives survival outcomes.
Conclusion
Our results represent a successful prediction of complex, dynamic physiological outcomes over a virtual population. Despite being informed by very limited data, our mechanistic model predicted a plausible range of treatment outcomes that accurately predicts changes in LD
50
when extrapolated to putatively toxic doses of bupivacaine. Furthermore, causal analysis of the predicted survival outcomes indicated a critical synergy between scavenging and direct cardiotonic mechanisms of ILE action.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original</subject><subject>Original Research Article</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><issn>1174-5886</issn><issn>1179-6901</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kctu1TAURSMEog_4AUYWc4Mdx48wQCq30Fa6iKpAp5ZjO-2pUjuynavej-CfSZqqEhNGtuSz1pH3rqp3lHyghMiPuSG1UJjUFBPCOMPNi-qQUtli0RL68vHeYK6UOKiOcr4jhFAm1OvqgDW1bFXTHFZ_LpN3YAuEG3QRik8YgoMduMkM6NokMB0MUPbodErLzBZGcOjK5ylbKKZADCj26Ms0ws5YA8GjjUkOYokPYBcQAroyJX9CJ-gaUlm8l3GchpX9Hp0fFvHPMrn9m-pVb4bs3z6dx9Xvb19_bc7x9sfZxeZki23DScGc1a2sLSeMGsKYV7WyyrD5c04SIXvetkL5TjHZOcml4pybTvLeKqlaP2PH1efVO07dvXfWh5LMoMcE9ybtdTSg_30JcKtv4k4rJpho5Sx4vwpiLqCXKLy9tTEEb4umiihRL1vqdcimmHPy_fMCSvTSoF4b1HOD-rFB3cwQW6E8LoH7pO_ilMKcxv-ovy9Rn6s</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>McDaniel, Matthew</creator><creator>Flores, Kevin B.</creator><creator>Akpa, Belinda S.</creator><general>Springer International Publishing</general><general>Springer</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>OTOTI</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6098-7113</orcidid><orcidid>https://orcid.org/0000-0002-4000-6971</orcidid><orcidid>https://orcid.org/0000000240006971</orcidid><orcidid>https://orcid.org/0000000260987113</orcidid></search><sort><creationdate>20210901</creationdate><title>Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study</title><author>McDaniel, Matthew ; Flores, Kevin B. ; Akpa, Belinda S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-532972c5031a033e828c8a3136d7067f59968eb837bd7578555ab75fc8789e503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original</topic><topic>Original Research Article</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McDaniel, Matthew</creatorcontrib><creatorcontrib>Flores, Kevin B.</creatorcontrib><creatorcontrib>Akpa, Belinda S.</creatorcontrib><creatorcontrib>Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>OSTI.GOV</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Drugs in R&D</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McDaniel, Matthew</au><au>Flores, Kevin B.</au><au>Akpa, Belinda S.</au><aucorp>Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study</atitle><jtitle>Drugs in R&D</jtitle><stitle>Drugs R D</stitle><date>2021-09-01</date><risdate>2021</risdate><volume>21</volume><issue>3</issue><spage>305</spage><epage>320</epage><pages>305-320</pages><issn>1174-5886</issn><eissn>1179-6901</eissn><abstract>Introduction
Intravenous lipid emulsions (ILE) have been credited for successful resuscitation in drug intoxication cases where other cardiac life-support methods have failed. However, inter-individual variability can function as a confounder that challenges our ability to define the scope of efficacy for lipid interventions, particularly as relevant data are scarce. To address this challenge, we developed a quantitative systems pharmacology model to predict outcome variability and shed light on causal mechanisms in a virtual population of rats subjected to bupivacaine toxicity and ILE intervention.
Materials and Methods
We combined a physiologically based pharmacokinetic–pharmacodynamic model with data from a small study in Sprague-Dawley rats to characterize individual-specific cardiac responses to lipid infusion. We used the resulting individual parameter estimates to posit a population distribution of responses to lipid infusion. On that basis, we constructed a large virtual population of rats (
N
= 10,000) undergoing lipid therapy following bupivacaine cardiotoxicity.
Results
Using unsupervised clustering to assign resuscitation endpoints, our simulations predicted that treatment with a 30% lipid emulsion increases bupivacaine median lethal dose (LD
50
) by 46% when compared with a simulated control fluid. Prior experimental findings indicated an LD
50
increase of 48%. Causal analysis of the population data suggested that muscle accumulation rather than liver accumulation of bupivacaine drives survival outcomes.
Conclusion
Our results represent a successful prediction of complex, dynamic physiological outcomes over a virtual population. Despite being informed by very limited data, our mechanistic model predicted a plausible range of treatment outcomes that accurately predicts changes in LD
50
when extrapolated to putatively toxic doses of bupivacaine. Furthermore, causal analysis of the predicted survival outcomes indicated a critical synergy between scavenging and direct cardiotonic mechanisms of ILE action.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34279844</pmid><doi>10.1007/s40268-021-00353-4</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-6098-7113</orcidid><orcidid>https://orcid.org/0000-0002-4000-6971</orcidid><orcidid>https://orcid.org/0000000240006971</orcidid><orcidid>https://orcid.org/0000000260987113</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1174-5886 |
ispartof | Drugs in R&D, 2021-09, Vol.21 (3), p.305-320 |
issn | 1174-5886 1179-6901 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8363697 |
source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection; Springer Nature OA Free Journals |
subjects | 60 APPLIED LIFE SCIENCES Internal Medicine Medicine Medicine & Public Health Original Original Research Article Pharmacology/Toxicology Pharmacotherapy |
title | Predicting Inter-individual Variability During Lipid Resuscitation of Bupivacaine Cardiotoxicity in Rats: A Virtual Population Modeling Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A05%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%20Inter-individual%20Variability%20During%20Lipid%20Resuscitation%20of%20Bupivacaine%20Cardiotoxicity%20in%20Rats:%20A%20Virtual%20Population%20Modeling%20Study&rft.jtitle=Drugs%20in%20R&D&rft.au=McDaniel,%20Matthew&rft.aucorp=Oak%20Ridge%20National%20Laboratory%20(ORNL),%20Oak%20Ridge,%20TN%20(United%20States)&rft.date=2021-09-01&rft.volume=21&rft.issue=3&rft.spage=305&rft.epage=320&rft.pages=305-320&rft.issn=1174-5886&rft.eissn=1179-6901&rft_id=info:doi/10.1007/s40268-021-00353-4&rft_dat=%3Cpubmedcentral_osti_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8363697%3C/pubmedcentral_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34279844&rfr_iscdi=true |